Arrowstreet Capital’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$927M Sell
3,425,381
-283,656
-8% -$84.5M 0.5% 32
2025
Q4
$1.22B Buy
3,709,037
+307,184
+9% +$104M 0.72% 20
2025
Q3
$1.17B Buy
3,401,853
+502,474
+17% +$152M 0.74% 20
2025
Q2
$905M Buy
2,899,379
+646,373
+29% +$247M 0.64% 26
2025
Q1
$1.18B Buy
2,253,006
+1,093,447
+94% +$559M 0.96% 11
2024
Q4
$587M Sell
1,159,559
-400,078
-26% -$227M 0.47% 41
2024
Q3
$912M Sell
1,559,637
-266,712
-15% -$151M 0.78% 20
2024
Q2
$930M Sell
1,826,349
-339,830
-16% -$167M 0.82% 16
2024
Q1
$1.07B Buy
2,166,179
+504,721
+30% +$257M 0.99% 12
2023
Q4
$875M Buy
1,661,458
+126,196
+8% +$67.3M 0.92% 19
2023
Q3
$774M Sell
1,535,262
-89,378
-6% -$44M 0.94% 22
2023
Q2
$781M Sell
1,624,640
-196,302
-11% -$96M 0.95% 17
2023
Q1
$861M Sell
1,820,942
-88,617
-5% -$42.8M 1.11% 10
2022
Q4
$1.01B Sell
1,909,559
-531,832
-22% -$282M 1.42% 5
2022
Q3
$1.23B Sell
2,441,391
-249,662
-9% -$131M 1.82% 5
2022
Q2
$1.38B Sell
2,691,053
-489
-0% -$246K 1.96% 4
2022
Q1
$1.37B Buy
2,691,542
+2,540,538
+1,682% +$1.23B 1.71% 5
2021
Q4
$75.8M Buy
151,004
+128,876
+582% +$58.3M 0.09% 228
2021
Q3
$8.65M Buy
22,128
+1,600
+8% +$663K 0.01% 790
2021
Q2
$8.22M Buy
20,528
+7,900
+63% +$3.15M 0.01% 901
2021
Q1
$4.7M Buy
12,628
+3,218
+34% +$1.12M 0.01% 1201
2020
Q4
$3.3M Sell
9,410
-10,400
-52% -$3.49M ﹤0.01% 1400
2020
Q3
$6.18M Buy
19,810
+10,910
+123% +$3.35M 0.01% 1058
2020
Q2
$2.63M Sell
8,900
-12,500
-58% -$3.58M ﹤0.01% 1350
2020
Q1
$5.34M Buy
+21,400
New +$5.89M 0.02% 716
2019
Q4
Sell
-18,855
Closed -$4.1M 1927
2019
Q3
$4.1M Sell
18,855
-1,741,124
-99% -$420M 0.01% 762
2019
Q2
$429M Buy
1,759,979
+32,680
+2% +$7.86M 0.96% 20
2019
Q1
$427M Buy
1,727,299
+32,625
+2% +$8.32M 1.01% 19
2018
Q4
$422M Buy
1,694,674
+727,540
+75% +$192M 1.11% 16
2018
Q3
$257M Sell
967,134
-190,102
-16% -$49.4M 0.58% 40
2018
Q2
$284M Sell
1,157,236
-2,224,337
-66% -$534M 0.7% 35
2018
Q1
$724M Sell
3,381,573
-941,607
-22% -$215M 1.66% 7
2017
Q4
$953M Buy
4,323,180
+792,527
+22% +$168M 2.29% 1
2017
Q3
$691M Buy
3,530,653
+2,227,585
+171% +$430M 1.85% 4
2017
Q2
$242M Buy
1,303,068
+300,744
+30% +$52.7M 0.73% 36
2017
Q1
$164M Buy
+1,002,324
New +$164M 0.6% 33
2016
Q4
Sell
-329,021
Closed -$46.1M 2505
2016
Q3
$46.1M Sell
329,021
-723,069
-69% -$101M 0.15% 151
2016
Q2
$149M Buy
1,052,090
+1,032,790
+5,351% +$138M 0.49% 45
2016
Q1
$2.49M Buy
+19,300
New +$2.28M 0.01% 736
2015
Q4
Sell
-391,423
Closed -$45.4M 1601
2015
Q3
$45.4M Sell
391,423
-691,397
-64% -$82.8M 0.22% 116
2015
Q2
$132M Buy
1,082,820
+438,336
+68% +$51.9M 0.75% 25
2015
Q1
$76.2M Sell
644,484
-1,187,476
-65% -$132M 0.47% 56
2014
Q4
$185M Sell
1,831,960
-332,223
-15% -$31.5M 1.06% 18
2014
Q3
$187M Buy
2,164,183
+1,324,854
+158% +$112M 1% 20
2014
Q2
$68.6M Buy
839,329
+240,939
+40% +$19M 0.35% 68
2014
Q1
$49.1M Sell
598,390
-149,739
-20% -$11.3M 0.3% 82
2013
Q4
$56.3M Buy
748,129
+708,544
+1,790% +$50.9M 0.31% 89
2013
Q3
$2.83M Buy
+39,585
New +$2.83M 0.02% 485

Other funds holding UNH

Arrowstreet Capital's UNH Position: Q1 2026 in Review

Arrowstreet Capital reduced its UnitedHealth (UNH) stake by 7.6% in Q1 2026, selling an estimated $84.5M and leaving 3,425,381 shares worth $927M. The position accounts for 0.5% of the portfolio, ranked #32.

Arrowstreet Capital first reported a position in UNH in Q3 2013 and has held it in 48 quarters since. The position peaked at $1.38B in Q2 2022. 3,019 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Arrowstreet Capital held 3,425,381 shares of UnitedHealth worth $927M as of Q1 2026.
  • Arrowstreet Capital sold 283,656 UnitedHealth shares in Q1 2026, an estimated $84.5M.
  • UnitedHealth made up 0.5% of Arrowstreet Capital's portfolio in Q1 2026, its #32 holding.
  • Arrowstreet Capital first reported a position in UnitedHealth in Q3 2013 and has held it in 48 quarters since.
  • Arrowstreet Capital's UnitedHealth position peaked at $1.38B in Q2 2022.
  • 3,019 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.